Compliance Without Compromise: How to Ensure EHR Data Integrity
At the AMIA Informatics Summit in 2025, researchers shared their promising EHR-to-EDC findings. They assessed five oncology trials across diverse...
OpenClinica’s Most Read Blogs of 2025
At OpenClinica, we publish a new blog most weeks. One of our favorite things to do is a mid-year checkup....
Adaptive by Nature: Modern Tools for Modern Trial Designs
Adaptive Platform Trials: Transforming Clinical Research with OpenClinica Adaptive platform trials (APTs) are transforming the way clinical research is conducted....
EHR-to-EDC Success in a Complex Oncology, Adaptive Platform Trial
At OpenClinica, we are especially proud of the work we are doing with the I-SPY 2 Trial, sponsored and operated...
Case Study: I-SPY 2 Delivers Personalized Oncology Treatments Faster
As we wrote in our new case study, The I-SPY series of trials are reshaping the future of personalized oncology...
Oncology Clinical Trials Case Study: I-SPY 2 & OpenClinica
Without a doubt, oncology clinical trials are among the most complex and complicated trials. Two of the primary reasons are:...





